Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2012-02-01

Clinical Trial Update: Topical Dexamethasone - Cyclodextrin Microparticle Eye Drops for Diabetic Macular Edema [Phase 2, Phase 3]

View source ↗

Summary

Update on a topical dexamethasone-cyclodextrin microparticle eye drop for diabetic macular edema. The trial is in Phase 2 and Phase 3, with current status unkno…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexamethasone-cyclodextrin microparticle eye drops (dexamethasone-cyclodextrin microparticle formulation)

Snippet

Sponsor: King Saud University | Conditions: Diabetic Macular Edema | Phase 2, Phase 3 | Status: UNKNOWN